Risk Stratification Value of Biomarkers in Patients With Myocarditis
Key facts
- Where
- Xi'an, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 80 years old?
Source: NCT06010199, who can take part
Where in China
- First Affiliated Hospital of Xi'an Jiaotong UniversityXi'an, ChinaContact: Guoliang LiTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- First Affiliated Hospital Xi'an Jiaotong University
- Trial code
- NCT06010199
- Record updated
- 12 July 2024
- Original description
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.Read full original descriptionShow less
Risk Stratification Value of Biomarkers in Patients With Myocarditis (FORWARD): a National, Multicenter, Retrospective-prospective, Cohort Study
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.
Inclusion: All patients should meet the diagnostic criteria for myocarditis; Patients who are regularly followed up at the corresponding cardiovascular center.
Exclusion: None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent; Age <3 years or >80 years; Pregnant or lactating women; The patient refused to sign the informed consent and refused to participate in the study.